Table 3 Echocardiographic parameters.

From: Exercise pulmonary hypertension in patients with systemic sclerosis based on updated guidelines

 

Non-PH (n = 21)

Ex-PH (n = 19)

Overt-PH (n = 18)

p value

Non-PH vs Overt-PH

Non-PH vs Ex-PH

Ex-PH vs Overt-PH

LVEF, %

65 ± 4

66 ± 5

62 ± 9

0.132

   

LAD, mm

32 (30–36)

33 (27–38)

31 (27–36)

0.972

   

LAVi, mL/m2

31 (26–36)

34 (28–38)

32 (27–46)

0.859

   

E, cm/s

67.7 ± 11.1

62.1 ± 15.0

64.8 ± 18.3

0.521

   

A, cm/s

69.7 ± 16.9

78.9 ± 14.6

76.1 ± 17.8

0.233

   

E/A

1.0 (0.8–1.2)

0.8 (0.7–1.0)

0.8 (0.7–0.9)

0.059

   

DcT, cm/s

182 ± 45

218 ± 54

228 ± 37

0.010

0.013

0.057

1.000

e’ septal, cm/s

7.4 ± 2.1

6.2 ± 1.7

6.0 ± 2.1

0.090

   

E/e’ septal, cm/s

9.8 ± 2.8

10.5 ± 3.1

11.3 ± 3.7

0.386

   

TVs’, cm/s

11.7 ± 1.7

12.8 ± 2.0

12.3 ± 2.1

0.244

   

TAPSE, mm

22 ± 3

22 ± 3

22 ± 4

0.913

   

RV FAC, %

41 ± 7

43 ± 7

38 ± 4

0.110

   

TAPSE/sPAP, mm/mmHg

0.73 ± 0.20

0.69 ± 0.19

0.55 ± 0.15

0.018

0.019

0.857

0.095

  1. Values are reported as mean ± standard deviation or medians (interquartile ranges).
  2. A late peak diastolic velocity of the mitral inflow, DcT deceleration time, E early peak diastolic velocity of the mitral inflow, e’ septal mitral annular motion with the sample volume placed in the septal, ex-PH exercise pulmonary hypertension, LAD left atrial diameter, LAVi left atrium volume index, LVEF left ventricular ejection fraction, PH pulmonary hypertension, RV FAC right ventricular fractional area change, sPAP systolic pulmonary arterial pressure, TAPSE tricuspid annular plane systolic excursion, TVs’ peak systolic velocity of tricuspid annulus.